Pre-clinical characterization of 1-7F9, a novel human anti-KIR therapeutic antibody that augments NK-mediated killing of tumor cells
暂无分享，去创建一个
M. Caligiuri | L. Ruggeri | A. Velardi | B. Blaser | É. Vivier | A. Moretta | L. Gauthier | P. André | F. Romagné | M. Chiesa | Nicolas Anfossi | N. Wagtmann | M. Capanni | P. Spee | S. Zahn | D. Benson | P. André